Posted by ABMN Staff on Apr 24th, 2024
Roth Mkm reiterated their buy rating on shares of Itron (NASDAQ:ITRI – Free Report) in a report released on Tuesday, Benzinga reports. The brokerage currently has a $102.00 price target on the scientific and technical instruments...
More of this article »